🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gregory A. Otterson

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

ORCID: 0000-0001-9877-8512

Also affiliated with The Ohio State University Wexner Medical Center, The Ohio State University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.104Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors

Cancer Investigation(2025)10.1080/07357907.2025.2557004
Top 78%
0.104DataRank
Top 78%1 citations

Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, Daniel Spakowicz +15 more

Papers

Driven by 28 papers — median percentile 11. Top paper: “Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration”.

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration

Nature Medicine(2020)10.1038/s41591-019-0716-8
N/A
0.898DataRank · unranked
397 citations

Jeffrey W. Clark, Jared Weiss, Sai‐Hong Ignatius Ou, D. Ross Camidge, Benjamin Solomon +16 more

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02674-w
N/A
0.571DataRank · unranked
44 citations

Daniel Spakowicz, Songzhu Zhao, Sandip H. Patel, Andrew Johns, Madison Grogan +11 more

Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer

The Oncologist(2023)10.1093/oncolo/oyad097
N/A
0.406DataRank · unranked
14 citations

Mike Yang, Lai Wei, Madison Grogan, Daniel Spakowicz, Sandipkumar Patel +10 more

Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03373-y
N/A
0.396DataRank · unranked
13 citations

Maria Riley, Songzhu Zhao, Jing Gennie Wang, Vince Esguerra, Mingjia Li +8 more

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer

Investigational New Drugs(2025)10.1007/s10637-025-01591-y
N/A
0.165DataRank · unranked
2 citations

Ruohan Wu, Lai Wei, Mikhail M. Dikov, Shankar Suman, Po‐Lan Su +17 more

Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors

Cancer Investigation(2025)10.1080/07357907.2025.2557004
Top 78%
0.104DataRank
Top 78%1 citations

Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, Daniel Spakowicz +15 more

Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.02.002
N/A
0DataRank · unranked
42 citations

Lai Wei, Madison Grogan, Rebecca Hoyd, John F. P. Bridges, Sandipkumar Patel +12 more

Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2633
N/A
0DataRank · unranked
11 citations

Menglin Xu, Sandipkumar Patel, Andrew Johns, Madison Grogan, Mingjia Li +13 more

Immune checkpoint inhibitor induced hepatitis: Risk factors, outcomes, and impact on survival.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e14525
N/A
0DataRank · unranked
2 citations

Songzhu Zhao, Sandip H. Patel, Andrew Johns, Madison Grogan, Mingjia Li +9 more

Bone modifying agents and skeletal related events in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18593
N/A
0DataRank · unranked
0 citations

Songzhu Zhao, Lai Wei, Abdul Miah, Mingjia Li, Gabrielle Lopez +11 more

Early changes in lymphocyte/monocyte ratio on-treatment as a prognostic marker to predict overall survival in patients with advanced cancer treated with immune checkpoint inhibitors

Research Square(2021)10.21203/rs.3.rs-758097/v1
Top 100%
0DataRank
Top 100%0 citations

Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, Daniel Spakowicz +14 more

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

Clinical Lung Cancer(2022)10.1016/j.cllc.2021.12.010
N/A
0DataRank · unranked
44 citations

Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li +17 more

Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

Journal of Cancer Research and Clinical Oncology(2022)10.1007/s00432-022-04340-3
N/A
0DataRank · unranked
40 citations

Gabriel Tinoco, Songzhu Zhao, Lai Wei, Andrew Johns, Sandip Pravin Patel +14 more

A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1552
N/A
0DataRank · unranked
36 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

442 Pre-treatment interstitial abnormalities is a risk factor for immune checkpoint inhibitor pneumonitis in patients with lung cancer

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0442
N/A
0DataRank · unranked
0 citations

Maria Riley, Songzhu Zhao, Jessica Zimmer, Matthew Viveiros, Jing Gennie Wang +10 more

Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03392-9
N/A
0DataRank · unranked
11 citations

Songzhu Zhao, Gabrielle Lopez, Austin Secor, Parthib Das, Nitya Surya +19 more

Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03371-0
N/A
0DataRank · unranked
11 citations

Mike Yang, Lai Wei, Madison Grogan, Sandipkumar Patel, Mingjia Li +9 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090
N/A
0DataRank · unranked
0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090.v1
N/A
0DataRank · unranked
0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Patterns of weight change and overall survival (OS) during first-line pembrolizumab treatment in patients with non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21094
N/A
0DataRank · unranked
0 citations

Songzhu Zhao, Kenneth Chian, Hyunwoo Kwon, Nicholas Jones, Adam Khorasanchi +15 more

Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung Cancer

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.07.002
N/A
0DataRank · unranked
0 citations

Philip Young, Songzhu Zhao, Lai Wei, Sandip H. Patel, Mingjia Li +17 more

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non‐Small‐Cell Lung Cancer Treated With Front‐Line Immunotherapy‐Based Therapies

Cancer Medicine(2025)10.1002/cam4.71058
N/A
0DataRank · unranked
0 citations

Po‐Lan Su, Songzhu Zhao, Grace Cheng, Nicholas Jones, Kenneth Chian +26 more

Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy

Lung Cancer(2025)10.1016/j.lungcan.2025.108832
N/A
0DataRank · unranked
0 citations

Mingjia Li, Songzhu Zhao, Lai Wei, Evelyn Goodyear, Kevin Ho +16 more

Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced Cancers

Cancer Management and Research(2020)10.2147/cmar.s264166
N/A
0DataRank · unranked
6 citations

Songzhu Zhao, Lai Wei, Kerry A. Rogers, Gregory A. Otterson, Tzu‐Fei Wang +2 more

540P Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy

Annals of Oncology(2020)10.1016/j.annonc.2020.08.654
N/A
0DataRank · unranked
1 citations

Filippo de Braud, Alexander Drilon, Robert C. Doebele, Manish R. Patel, Byoung Chul Cho +15 more

A phase II study of atezolizumab and cobimetinib in PD-1/PD-L1 inhibitor resistant or refractory non-small cell lung cancer: ETCTN #10166.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9638
N/A
0DataRank · unranked
1 citations

Richard D. Hall, Andreas Saltos, Gregory A. Otterson, Ming Tan, Sacha Gnjatic +5 more

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

UNC Libraries(2020)10.17615/74ry-7003
N/A
0DataRank · unranked
0 citations

Editta Baldini, Pierre-Jean Souquet, Grace K. Dy, Ariel López-Chávez, Federico Cappuzzo +25 more

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-03068-2
N/A
0DataRank · unranked
47 citations

Songzhu Zhao, Mingjia Li, Sandip H. Patel, Andrew Johns, Madison Grogan +13 more